Fund moves
16.2%Stake
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 9, 2026 · Filed Nov 9, 2026
An Orchestra Biomed director paid $100K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 6 months.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$100,000
Shares × reported transaction price
$100K–$500K
+20.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 6 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 2 earlier confirmed purchases
5 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $5.70 on Nov 9, 2026, 63% above its 52-week low and 10% below its high, after a 3% drop over the previous 30 trading days
52-week range $3.49 (Jan 30, 2026) to $6.35 (Oct 1, 2026), 77% of the way up, from 251 adjusted closes. 30 trading days earlier: $5.89 on Sep 28, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
5 OBIO insiders bought within the same week; no week in filings since 2020 had that many buyers. Eric S Fain's largest purchase of OBIO in their filings since 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Fund moves
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed 3 days later
A major shareholder of Orchestra Biomed paid $6M out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 19 months.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
The CFO of Orchestra Biomed paid $5K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 15 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.